Samsung Pharmaceutical Co., Ltd. (001360)
Market Closed
4 Jul, 04:46
KRX SM KRX SM Primary ₩
1,708. 00
-8
-0.47%
₩
161.6B Market Cap
- P/E Ratio
0% Div Yield
172,951 Volume
- Eps
₩ 1,716
Previous Close Day Range
1,702 1,726
Year Range
1,388 2,220
Want to track 001360 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 39 days
| 001360 Samsung Pharmaceutical Co., Ltd. 12 Aug 2025 (In 1 month) | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 14 May 2025 | | - Cons. EPS | 395.75 EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 11 Mar 2025 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 12 Nov 2024 | | - Cons. EPS | 194.72 EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 14 Aug 2024 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 12 Aug 2024 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 16 May 2024 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 13 May 2024 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 13 Mar 2024 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 11 Mar 2024 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 8 Mar 2024 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 5 Mar 2024 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 14 Nov 2023 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 13 Nov 2023 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 31 Dec 2016 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 30 Sep 2016 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 30 Jun 2016 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 31 Mar 2016 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 31 Dec 2015 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 30 Sep 2015 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 30 Jun 2015 | | - Cons. EPS | 153.62 EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 31 Mar 2015 | | - Cons. EPS | 7.47 EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 31 Dec 2014 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 30 Sep 2014 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 30 Jun 2014 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 31 Mar 2014 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 31 Dec 2013 | | - Cons. EPS | - EPS |
| 001360 Samsung Pharmaceutical Co., Ltd. 30 Jun 2013 | | - Cons. EPS | 6.38 EPS |
001360 Earnings Reports FAQ
What is the company's earnings growth rate?
Over the past 12 years, the earnings growth rate has been approximately 45.53%, reflecting the 001360's performance and KRX SM market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2025-08-12, based on the 001360's typical earnings announcement schedule.
2025 © Marketlog. All Rights Reserved.
